Ouabain inhibition of the sodium-potassium pump: estimation of ED50 in different types of human leucocytes in vitro.

por Møller, B, Vaag, A, Johansen, T
Publicado 1990

Decreased insulin activation of glycogen synthase in skeletal muscles in young nonobese Caucasian first-degree relatives of patients with non-insulin-dependent diabetes mellitus.

por Vaag, A, Henriksen, J E, Beck-Nielsen, H
Publicado 1992

Timing of inter-generational prevention of adiposity and type 2 diabetes

por Vaag, A, Arora, G P, Thaman, R G
Publicado 2012

NovoSol Basal: pharmacokinetics of a novel soluble long acting insulin analogue.

por Jørgensen, S., Vaag, A., Langkjaer, L., Hougaard, P., Markussen, J.
Publicado 1989

The disposition index: adjustment for peripheral vs. hepatic insulin sensitivity?

por Færch, K, Brøns, C, Alibegovic, A C, Vaag, A
Publicado 2010

Insulin secretion, insulin action, and hepatic glucose production in identical twins discordant for non-insulin-dependent diabetes mellitus.

por Vaag, A, Henriksen, J E, Madsbad, S, Holm, N, Beck-Nielsen, H
Publicado 1995

The thrifty phenotype hypothesis revisited

por Vaag, A. A., Grunnet, L. G., Arora, G. P., Brøns, C.
Publicado 2012

Effect of the antilipolytic nicotinic acid analogue acipimox on whole-body and skeletal muscle glucose metabolism in patients with non-insulin-dependent diabetes mellitus.

por Vaag, A, Skött, P, Damsbo, P, Gall, M A, Richter, E A, Beck-Nielsen, H
Publicado 1991

Increased glucose effectiveness in normoglycemic but insulin-resistant relatives of patients with non-insulin-dependent diabetes mellitus. A novel compensatory mechanism.

por Henriksen, J E, Alford, F, Handberg, A, Vaag, A, Ward, G M, Kalfas, A, Beck-Nielsen, H
Publicado 1994

Treatment with a proton pump inhibitor improves glycaemic control in Psammomys obesus, a model of type 2 diabetes

por Bödvarsdóttir, T. B., Hove, K. D., Gotfredsen, C. F., Pridal, L., Vaag, A., Karlsen, A. E., Petersen, J. S.
Publicado 2010

Liraglutide vs insulin glargine and placebo in combination with metformin and sulfonylurea therapy in type 2 diabetes mellitus (LEAD-5 met+SU): a randomised controlled trial

por Russell-Jones, D., Vaag, A., Schmitz, O., Sethi, B. K., Lalic, N., Antic, S., Zdravkovic, M., Ravn, G. M., Simó, R.
Publicado 2009

Leukocyte telomere length is associated with elevated plasma glucose and HbA1c in young healthy men independent of birth weight

por Grunnet, L. G., Pilgaard, K., Alibegovic, A., Jensen, C. B., Hjort, L., Ozanne, S. E., Bennett, M., Vaag, A., Brøns, C.
Publicado en Sci Rep (2019)

Programming of adipose tissue miR-483-3p and GDF-3 expression by maternal diet in type 2 diabetes

por Ferland-McCollough, D, Fernandez-Twinn, D S, Cannell, I G, David, H, Warner, M, Vaag, A A, Bork-Jensen, J, Brøns, C, Gant, T W, Willis, A E, Siddle, K, Bushell, M, Ozanne, S E
Publicado 2012